Results 161 to 170 of about 347,846 (181)

Dissecting the prognostic signature of patients with astrocytoma isocitrate dehydrogenase-mutant grade 4: a large multicenter, retrospective study. [PDF]

ESMO Open
Dipasquale A, Franceschi E, Giordano L, Maccari M, Barigazzi C, Di Nunno V, Losurdo A, Persico P, Di Muzio A, Navarria P, Pessina F, Padovan M, Santoro A, Lombardi G, Simonelli M.   +14 more
europepmc   +1 more source

Ivosidenib in Chinese patients with relapsed or refractory isocitrate dehydrogenase 1 mutated acute myeloid leukemia: a registry study. [PDF]

Blood Sci
Sun M, Yin Q, Liang Y, Chang C, Zheng J, Li J, Ji C, Qiu H, Li J, Gong Y, Luo S, Zhang Y, Chen R, Shen Z, Yue Z, Wang S, Shi Q, Yang J, Jin J, Wang J.   +19 more
europepmc   +1 more source

Predictive machine learning models based on VASARI features for WHO grading, isocitrate dehydrogenase mutation, and 1p19q co-deletion status: a multicenter study. [PDF]

Am J Cancer Res
Zhao W, Xie C, Hanjiaerbieke K, Xu R, Pahati T, Wang S, Li J, Wang Y.   +7 more
europepmc   +1 more source

Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery. [PDF]

Neuro Oncol
Park YW, Jang G, Kim SB, Choi K, Han K, Shin NY, Ahn SS, Chang JH, Kim SH, Lee SK, Jain R.   +10 more
europepmc   +1 more source

The Correlation Patterns of miRNA Expression with Targeted mRNA Transcripts in Glioma Patients with Wild-Type and Mutated Isocitrate Dehydrogenase (IDH) Genotypes. [PDF]

Acta Naturae
Bondarev AA, Evpak AS, Novoselov AL, Kudriaeva AA, Jr Belogurov AA.   +4 more
europepmc   +1 more source

Circulating Oncometabolite 2-hydroxyglutarate as a Potential Biomarker for Isocitrate Dehydrogenase (IDH1/2) Mutant Cholangiocarcinoma. [PDF]

Mol Cancer Ther
Lee CL, O'Kane GM, Mason WP, Zhang WJ, Spiliopoulou P, Hansen AR, Grant RC, Knox JJ, Stockley TL, Zadeh G, Chen EX.   +10 more
europepmc   +1 more source

SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma. [PDF]

Sci Transl Med
Luk IS, Bridgwater CM, Yu A, Boila LD, Yáñez-Bartolomé M, Lampano AE, Hulahan TS, Boukhali M, Kathiresan M, Macarulla T, Kenerson HL, Yamamoto N, Sokolov D, Engstrom IA, Sullivan LB, Lampe PD, Cooper JA, Yeung RS, Tian TV, Haas W, Saha SK, Kugel S.   +21 more
europepmc   +1 more source

Epithelial differentiation mimicking tumor-to-tumor metastasis in an isocitrate dehydrogenase wild-type glioblastoma. [PDF]

Neurooncol Adv
Gruchala T, Smith H, Khan O, Jennings L, Santana-Santos L, Vormittag-Nocito E, Horbinski C.   +6 more
europepmc   +1 more source